Abstracts Archive - Page 1698 of 2425 - ACR Meeting Abstracts

Abstract Number: 124 • 2015 ACR/ARHP Annual Meeting
Experiences with a Structured Questionnaire for Administrative Personnel to Discriminate Urgent and Non-Urgent Rheumatic Patients Referred from Primary to Secondary Care
Omar Ghazal and Michael Schirmer, Internal Medicine, Clinic VI, Medical University of Innsbruck, Innsbruck, Austria
Background/Purpose: To gain experiences with a structured questionnaire for discriminating urgent and non-urgent rheumatology appointments by administrative personnel, designed to include all forms of rheumatic…
Abstract Number: 125 • 2015 ACR/ARHP Annual Meeting
Implementation of a Bone Health Team Markedly Improves Osteoporosis Screening, Diagnosis and Treatment Initiation Rates Compared to Standard Primary Care Practice
Karla L. Miller^1,2, Marissa P. Grotzke¹, Phillip Lawrence³, Yanina Rosenblum⁴, Richard Nelson^5,6, Joanne Lafleur^7,8 and Grant W. Cannon¹, ¹Internal Medicine, Veterans Affairs Salt Lake City Health Care System, Salt Lake City, UT, ²Internal Medicine-Division of Rheumatology, University of Utah School of Medicine, SLC, UT, ³Pharmacology, Salt Lake City VA Medical Center and University of Utah, Salt Lake City, UT, ⁴Veterans Affairs Salt Lake City Health Care System, Salt Lake City, UT, ⁵Epidemiology, Veterans Affairs Salt Lake City Health Care System, Salt Lake City, UT, ⁶Division of Epidemiology, University of Utah School of Medicine, Salt Lake City, UT, ⁷Pharmacology, Veterans Affairs Salt Lake City Health Care System, Salt Lake City, UT, ⁸University of Utah College of Pharmacy, Salt Lake City, UT
Background/Purpose: Despite the availability of effective therapies for fracture prevention, osteoporosis screening and treatment rates in practice are low. Fracture liaison services are effective at…
Abstract Number: 126 • 2015 ACR/ARHP Annual Meeting
Patients with Osteoarthritis and Rheumatoid Arthritis Seen at 4 Different Routine Rheumatology Care Sites at This Time Have Similar and Patient and Physician Global Estimates of Severity, and Scores for Functional Disability, Pain, and RAPID3
Carlos El-Haddad¹, Isabel Castrejón², Kathryn A. Gibson³, Yusuf Yazici⁴, Martin Bergman⁵ and Theodore Pincus², ¹Rheumatology, Liverpool Hospital, NSW, Australia, ²Rheumatology, Rush University Medical Center, Chicago, IL, ³Liverpool Hospital, Liverpool, Australia, ⁴NYU Hospital for Joint Diseases, New York, NY, ⁵Division of Rheumatology, Taylor Hospital, Ridley Park, PA
Background/Purpose: RA generally is regarded by physicians and the public as a more severe problem than OA. However, OA has been ranked as the 11th…
Abstract Number: 127 • 2015 ACR/ARHP Annual Meeting
Potential Use of Healthcare Databases for Post-Marketing Surveillance Registry: an Example Using Ustekinumab
Huifeng Yun¹, Shuo Yang², Fenglong Xie³, Lang Chen⁴, Kevin L. Winthrop⁵ and Jeffrey R. Curtis⁴, ¹Epidemiology, University of Alabama at Birmingham, Birmingham, AL, ²Clinical Immunology/Rheumatology, University of Alabama at Birmingham, Birmingham, AL, ³Rheumatology & Immunology, University of Alabama at Birmingham, Birmingham, AL, ⁴University of Alabama at Birmingham, Birmingham, AL, ⁵Oregon Health and Science University, Portland, OR
Background/Purpose: Underreporting and inherent deficiencies are common using spontaneous reports for post-marketing surveillance. The U.S. Food and Drug Administration (FDA) has recommended sponsors to collect…
Abstract Number: 128 • 2015 ACR/ARHP Annual Meeting
Economic Burden and Treatment Patterns of Cycling Between Non-Biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs) Among Patients with Rheumatoid Arthritis (RA)
Nanxin Li¹, Keith Betts¹, Jenny Griffith², Ljubica Ristovska¹, Kevin Douglas² and Arijit Ganguli², ¹Analysis Group, Inc., Boston, MA, ²AbbVie Inc., North Chicago, IL
Background/Purpose: RA patients with inadequate treatment response often cycle non-biologic DMARDs before initiating a biologic DMARD. Early and aggressive treatment is a key feature of…
Abstract Number: 129 • 2015 ACR/ARHP Annual Meeting
Rheumatologists’ Approaches to Diagnosis and Treatment of Depression
Erica Heiman, Barton Wise and Richard L. Kravitz, Department of Internal Medicine, UC Davis Medical Center, Sacramento, CA
Background/Purpose: Depression in patients with rheumatic disorders contributes to morbidity, mortality, and health care utilization. We set out to examine rheumatologists’ approaches to and perceptions…
Abstract Number: 130 • 2015 ACR/ARHP Annual Meeting
Disease Activity Patterns in Incident Onset Rheumatoid Arthritis Patients in the First 3-Years of Follow up
Mark Tatangelo¹, George A. Tomlinson², Bindee Kuriya³ and Claire Bombardier⁴, ¹University of Toronto, Toronto, ON, Canada, ²Medicine, Mount Sinai Hospital, Toronto, ON, Canada, ³Rheumatology, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada, ⁴Toronto General Hospital Research Institute, University Health Network, Toronto, ON, Canada
Background/Purpose: Disease progression in longitudinal studies of rheumatoid arthritis (RA) is usually assessed by examining a measure of disease over time fixed time intervals. We…
Abstract Number: 131 • 2015 ACR/ARHP Annual Meeting
Frequency of Lipid Testing and Management Among Rheumatoid Arthritis Patients Compared to the General Population and Patients with Diabetes
Iris Navarro-Millan¹, Shuo Yang², Monica Safford³, Lang Chen³, Huifeng Yun⁴ and Jeffrey R. Curtis³, ¹Rheumatology, University of Alabama at Birmingham, Birmingham, AL, ²Clinical Immunology/Rheumatology, University of Alabama at Birmingham, Birmingham, AL, ³University of Alabama at Birmingham, Birmingham, AL, ⁴Epidemiology, University of Alabama at Birmingham, Birmingham, AL
Background/Purpose: Patients with rheumatoid arthritis (RA) have high coronary heart disease (CHD) burden and accelerated atherosclerotic status. However, limited data suggest that these patients may…
Abstract Number: 132 • 2015 ACR/ARHP Annual Meeting
Delivering a One-Stop, Integrated, Patient-Centred Service for Patients with Rheumatic Diseases. the Finnish Approach
Elena Nikiphorou¹, Paula Väre¹, Kirsi Paalanen¹, Jelena Borodina¹, Arto Kokko², Pekka Hannonen¹ and Tuulikki Sokka-Isler³, ¹Jyvaskyla Central Hospital, Jyvaskyla, Finland, ²Jyvaskyla Central Hospital, Jyväskylä, Finland, ³Rheumatology, Jyvaskyla Central Hospital, Jyvaskyla, Finland
Background/Purpose: Rheumatology is mainly an outpatient specialty. Prompt diagnosis & treatment to prevent long-term disability in an integrated, multi-disciplinary approach to care are crucial. In reality though,…
Abstract Number: 133 • 2015 ACR/ARHP Annual Meeting
Advocating for Rheumatoid Arthritis and Cardiovascular Health (ARCH) in a Tertiary Referral Center: A Collaborative and Systems-Based Approach to Improve Access to Care
Barbara Goldstein¹, JoAnn Zell¹, Pearlanne Zelarney², Matthew Stern², Sarah Meadows², Meg Dingae², Carmen Egidio² and Darlene Kim², ¹Medicine, National Jewish Health, Denver, CO, ²National Jewish Health, Denver, CO
Background/Purpose: Patients with rheumatoid arthritis (RA) have an increased risk of cardiovascular disease (CVD) as compared to the general population. The European League Against Rheumatism…
Abstract Number: 134 • 2015 ACR/ARHP Annual Meeting
Axial Spondyloarthritis: Validation of an Inter-Professional Model of Care
Christopher Hawke¹, Laura Passalent^2,3, Anthony V. Perruccio⁴, Kala Sundararajan⁵, Nigil Haroon⁶, Robert D Inman⁷ and Y. Raja Rampersaud⁸, ¹Toronto Western Hospital, University of Toronto, Toronto, ON, Canada, ²Allied Health, Toronto Western Hospital, Toronto, ON, Canada, ³Physical Therapy, University of Toronto, Toronto, ON, Canada, ⁴Orthopaedic Surgery, Brigham & Women's Hospital and Harvard Medical School, Boston, MA, ⁵Orthopaedic Research Department, Toronto Western Hospital, Toronto, ON, Canada, ⁶Rheumatology, Toronto Western Hospital, University of Toronto, Toronto, ON, Canada, ⁷Immunlogy and Institute of Medical Science, Toronto Western Hospital, University of Toronto, Toronto, ON, Canada, ⁸Orthopaedic Surgery and Neurosurgery, University Health Network and University of Toronto, Toronto, ON, Canada
Background/Purpose: Early detection of axial Spondyloarthritis (axSpA) is challenging given the lack of pathognomonic clinical findings. Clinical overlap with mechanical back pain leaves axSpA a…
Abstract Number: 135 • 2015 ACR/ARHP Annual Meeting
Limitations of Treat-to-Target in Rheumatoid Arthritis: Joint Damage Appears As Severe As Inflammation in Contemporary Care at One Site
Theodore Pincus¹, Alex D. Luta², Isabel Castrejón¹, Annie Huang¹, Ruchi Jain¹, Sarah L. Everakes³ and Joel A. Block⁴, ¹Rheumatology, Rush University Medical Center, Chicago, IL, ²Georgetown University, Washington, DC, ³Internal Medicine, Rush University Medical Center, Chicago, IL, ⁴Rush University Medical Center, Chicago, IL
Background/Purpose: Treatment of rheumatoid arthritis is directed to “treat-to-target,” with intensification of therapy in patients with moderate/high disease activity according to a quantitative index toward…
Abstract Number: 136 • 2015 ACR/ARHP Annual Meeting
Physician Patterns of Patient Care in Systemic Lupus Erythematosus: Are We Ordering Unnecessary Tests?
Aman Kugasia¹, Meenakshi Jolly², Winston Sequeira³, Ailda Nika³, Neha Sehgal⁴ and Mary Dollear⁵, ¹Internal Medicine, John H Stroger Hospital of Cook County, Chicago, IL, ²Department of Medicine, Section of Rheumatology, Rush University Medical Center, Chicago, IL, ³Rheumatology, Rush University Medical Center, Chicago, IL, ⁴Indiana University- Bloomington, Valparaiso, IN, ⁵Vice President, Lupus Society of Illinois, Chicago, IL
Background/Purpose: To plan a quality improvement project, we need to understand the practice patterns of physicians. We undertook an online survey of physicians (MDs) (Rheumatologists,…
Abstract Number: 137 • 2015 ACR/ARHP Annual Meeting
Willingness to Pay for Highly Effective Drug Treatments in Brazilian Rheumatoid Arthritis Patients
Cleandro Albuquerque¹, Pedro Haddad², Vander Fernandes³, Claudia Marques⁴, Sonia Fialho⁵, Adriana Kakehasi⁶, Fabio Jennings⁷, Claiton Brenol⁸, Lícia M. H. Mota^9,10, Geraldo Castelar-Pinheiro^2,11, Angela Duarte¹², Iara Giroto¹³, Maria Raquel C. Pinto¹⁴, Mariana Toni¹⁵, Mirhelen Mendes Abreu¹⁶ and Marcos B. Ferraz¹⁷, ¹Rheumatology, Hospital Universitário de Brasília - UnB, Brasília, Brazil, ²Universidade do Estado do Rio de Janeiro - UERJ, Rio de Janeiro, Brazil, ³Universidade de Cuiabá, Cuiaba MT, Brazil, ⁴Disciplina de Reumatologia, Hospital das Clínicas - Universidade Federal de Pernambuco, Recife - PE, Brazil, ⁵Rodovia Virgílio Várzea 1510 B, Universidade Federal de Santa Catarina, Florianópolis, Brazil, ⁶Rua Astolfo Vieira de Resende, Faculdade de Medicina - UFMG, Belo Horizonte, Brazil, ⁷Disciplina de reumatologia, Universidade Federal de São Paulo, Sao Paulo, Brazil, ⁸Universidade Federal do Rio Grande do Sul, Porto Alegre RS, Brazil, ⁹Rheumatology, University Hospital, Faculty of Medicine, University of Brasília, Brasília/DF, Brazil, ¹⁰Hospital Universitário de Brasília - UnB, Brasília, Brazil, ¹¹Discipline of Rheumatology, Rio de Janeiro State University, Rio de Janeiro, Brazil, ¹²Internal Medicine, Hospital das Clínicas - UFPE, Recife, Brazil, ¹³Universidade de Cuiabá, Cuiabá, Brazil, ¹⁴Universidade Federal de Minas Gerais, Belo Horizonte, Brazil, ¹⁵Faculdade de Medicina - UFRGS, Porto Alegre, Brazil, ¹⁶Disciplina de Reumatologia, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil, ¹⁷Universidade Federal de São Paulo, São Paulo, Brazil
Background/Purpose: Willingness to pay (WTP) is a technique used for valuing health benefits and individual preferences. Brazil’s national public health system (Sistema Único de Saúde)…
Abstract Number: 138 • 2015 ACR/ARHP Annual Meeting
Identification and Documentation of Secondary Osteoarthritis in Patients with Primary Inflammatory Arthritides Using a Patient MDHAQ/RAPID3 and a Physician Estimate of Joint Damage to Recognize Patient Complexity and Inform Management Decisions
Kathryn A. Gibson¹, Annie Huang², Katherine J. Bryant³ and Theodore Pincus², ¹Liverpool Hospital, Liverpool, Australia, ²Rheumatology, Rush University Medical Center, Chicago, IL, ³University of New South Wales, Sydney, Australia
Background/Purpose: Patients with inflammatory arthritides may have secondary osteoarthritis (OA), which affects decisions concerning clinical management. For example, in one study, about 20% of patients…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].